Blood cancers

Podcast: How the treatment landscape has changed for the better in relapsed-refractory CLL

Sponsored by Janssen-Cilag Pty Ltd

Recent approvals of novel agents together with the ongoing development of combination regimes has opened up a realm of treatment options for people with chronic lymphocytic leukaemia. In this podcast we speak to Professor Paolo Ghia, Associate Professor in Internal Medicine at the Università Vita-Salute San Raffaele and local haematologist, Professor Stephen Opat, a Member of the Monash ...

Already a member?

Login to keep reading.

© 2021 the limbic